Surgery and laser for glioblastoma on both sides
Part of Brain & nervous system, Cancer clinical trials.
This study tests a treatment for glioblastoma that affects both sides of the brain. It combines surgery to remove as much tumor as possible with a laser treatment (LITT) to destroy the smaller tumor on the other side.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a glioblastoma tumor in both the left and right sides of your brain.
- The smaller tumor (or the part remaining after surgery) must be less than 2.5 cm (about 1 inch).
- You should feel well enough to do most of your daily activities on your own (performance status 0 or 1).
- You must be able to understand the study and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive laser procedure (LITT) to treat glioblastoma that comes back very soon after initial treatment. The goal is to see if laser heat can destroy the tumor before standard radiation and chemotherapy begin, potentially improving outcomes.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This study tests a laser ablation treatment for people whose high-grade glioma (a fast-growing brain tumor) has come back after standard therapy. The goal is to see if this minimally invasive laser procedure can help control the tumor.
This trial tests a combination of MRI-guided laser surgery, a wearable device (Optune) that sends electric fields to the brain, and an immunotherapy drug (pembrolizumab/Keytruda) for people whose glioblastoma has come back. The goal is to see if this approach is safe and works better than standard treatments.
This study tests a treatment that uses a laser to heat and destroy the recurring brain tumor during a procedure called LITT, followed by an immunotherapy drug called cemiplimab that helps your immune system fight the cancer. This might help people whose glioblastoma has come back after standard treatments.
This trial tests a stronger combination of treatments given after surgery for people with glioblastoma (GBM) that was only partially removed or that starts growing again quickly. It aims to see if this approach can help control the tumor better. You may be eligible if you are newly diagnosed, over 18, have good organ function, and do not have other serious health issues.
Hear when a new GBM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.